Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Argus Health
Baxter
Chinese Patent Office
Colorcon
McKesson
Daiichi Sankyo
QuintilesIMS

Generated: December 15, 2018

DrugPatentWatch Database Preview

TIROSINT Drug Profile

« Back to Dashboard

When do Tirosint patents expire, and when can generic versions of Tirosint launch?

Tirosint is a drug marketed by Institut Biochimique and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has nineteen patent family members in nine countries.

The generic ingredient in TIROSINT is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Drug patent expirations by year for TIROSINT
Pharmacology for TIROSINT
Drug Classl-Thyroxine
Synonyms for TIROSINT
(-)-Thyroxine Sodium
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt
(S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt
054I36CPMN
137-53-1
25416-65-3
3,3?,5,5?-Tetraiodo-L-thyronine sodium salt
3,3',5,5'-Tetraiodo-L-thyronine Sodium
3,3',5,5'-Tetraiodo-L-thyronine sodium salt
3,3',5,5'-Tetraiodo-L-thyronine, sodium salt
50809-32-0
55-03-8
6260AF
67809-22-7
A830452
AC-10210
AC-919
AK-46618
AKOS015918420
AKOS024284731
AM016770
API0007805
BBC/815
BC204258
Berlthyrox
C08212
C15H10I4NO4.Na
CHEBI:6446
CT-452
CTK4J3191
D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt
Dathroid
EBD2201200
Eferox
EINECS 200-221-4
eltroxin
Epitope ID:136776
Euthyrox
FT-0628030
FT-0658959
Henning Sodium
I14-8105
J-524276
KS-00000F9R
L-T4 Sodium
L-Thyroxin Sodium
l-Thyroxine monosodium salt
L-Thyroxine sodium
L-Thyroxine sodium salt
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI)
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)
Laevoxin
Letter
Levaxin
Leventa
Levo-T
Levolet
Levoroxine
levothroid
Levothyrox
Levothyroxin-natrium
Levothyroxine sodique
Levothyroxine sodique [INN-French]
Levothyroxine sodium
Levothyroxine Sodium (anhydrous)
Levothyroxine Sodium [USAN:INN]
Levothyroxine Sodium [USAN]
Levothyroxine sodium anhydrous
Levothyroxine sodium tablets
Levothyroxinum natricum
Levothyroxinum natricum [INN-Latin]
levotiroxina de sodio
Levotiroxina sodica
Levotiroxina sodica [INN-Spanish]
Levoxyl
LS-153817
LS-153822
MolPort-002-511-861
Monosodium L-thyroxine
Novothyrox
NSC 259940
NSC 36397-Sodium
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine Sodium
Oroxine
RL03895
RL04067
Ro-thyroxine
Roxstan
SCHEMBL34102
sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate
Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate
sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine
Sodium l-thyroxin
Sodium L-thyroxine
Sodium levothyroxine
SODIUM LEVOTHYROXINE(1-)
Sodium thyroxin
Sodium thyroxinate
Sodium thyroxine
Sodium-L-thyroxine
Sodiumlevothyroxine
Soloxine
ST078859
STOCK1N-15023
Synthroid sodium
T4 Sodium
Tetroid
Thevier
Thyradin
Thyradin S
Thyrax Sodium
Thyreoideum Sodium
Thyro-Tabs
THYROID
Thyronamin
Thyrosit
Thyroxevan
Thyroxin sodium
Thyroxinal Sodium
Thyroxine sodique
Thyroxine sodium
Thyroxine sodium salt
Thyroxine, monosodium salt, L-
Thyroxinique
Thyroxinum natricum
Tiroidina
Tirosint-Sol
Tyrosint
UNII-054I36CPMN
Unithroid
YDTFRJLNMPSCFM-YDALLXLXSA-M
Z2798529463

US Patents and Regulatory Information for TIROSINT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-010 Dec 15, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-006 Dec 15, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-011 Dec 15, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-007 Dec 15, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-013 Aug 1, 2007 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TIROSINT
Drugname Dosage Strength RLD Date
➤ Subscribe Capsules 75 mcg and 150 mcg ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Argus Health
Baxter
Chinese Patent Office
Colorcon
McKesson
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.